Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-8427 in HABP/VABP
NCT06841731Phase 2Completed
- Sponsor
- Hengrui
- Start
- Apr 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-8427 in hospital-acquired bacterial pneumonia (HAP), ventilator-associated pneumonia (VAP), sponsored by Hengrui. Started Apr 2025; status: completed.
02
Drugs
HRS-8427
03
Conditions
hospital-acquired bacterial pneumonia (HAP)ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT06841731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06841731.